Patrick Stiff

11PUBLICATIONS

78CO-AUTHORS

Applied immunology (incl. antibody engineering, xenotransplantation and t-cell therapies)Haematological tumoursCardiovascular medicine and haematology not elsewhere classifiedCancer therapy (excl. chemotherapy and radiation therapy)Haematology

Get your video featured.

Publish with JoVE

Get your video featured.

Publish with JoVE

Publications (11)

Sort by Publication Date:

|Jun 22, 2026

Itacitinib plus calcineurin inhibitor-based therapy for prophylaxis of graft-versus-host disease: GRAVITAS-119 results.

|Mar 20, 2025

Three-year analysis of adult patients with relapsed or refractory B-cell acute lymphoblastic leukemia treated with brexucabtagene autoleucel in ZUMA-3.

Bijal D Shah, Ryan D Cassaday, Jae H Park

|Sep 19, 2024

Randomized Phase III SIERRA Trial of <sup>131</sup>I-Apamistamab Before Allogeneic Hematopoietic Cell Transplantation Versus Conventional Care for Relapsed/Refractory AML.

Boglarka Gyurkocza, Rajneesh Nath, Stuart Seropian

|Jan 04, 2024

Long-term outcomes of patients with large B-cell lymphoma treated with axicabtagene ciloleucel and prophylactic corticosteroids.

Olalekan O Oluwole, Edouard Forcade, Javier Muñoz

|Nov 15, 2023

Nonactivated and IL-7 cultured CD19-specific CAR T cells are enriched in stem cell phenotypes and functionally superior.

Siao-Yi Wang, Gina M Scurti, Annika V Dalheim

|Apr 17, 2023

Motixafortide and G-CSF to mobilize hematopoietic stem cells for autologous transplantation in multiple myeloma: a randomized phase 3 trial.

Zachary D Crees, Michael P Rettig, Reyka G Jayasinghe

Pageof 2

Frequent Collaborators

Yi Lin

John M Pagel

Abhinav Deol

Olalekan O Oluwole

Camille N Abboud

Miguel Angel Perales

Pinkal M Desai

Saar Gill

Melham M Solh

John Lister

Frequent Collaborators

Yi Lin

John M Pagel

Abhinav Deol

Olalekan O Oluwole